NCT02318563View on ClinicalTrials.gov

Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 30, 2017

Primary Completion Date

June 17, 2018

Study Completion Date

June 17, 2018

Conditions
Dravet Syndrome
Interventions
DRUG

Cannabidiol Oral Solution

An oral solution containing pharmaceutical grade cannabidiol (nonplant-based)

DRUG

Placebo Solution

A matching oral solution containing no cannabidiol

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY